HBLFX | MRMUX | HBLFX / MRMUX | |
Total Expense Ratio | 0.56 | 0.59 | 95% |
Annual Report Gross Expense Ratio | 0.56 | 0.59 | 95% |
Fund Existence | 8 years | 11 years | - |
Gain YTD | 4.096 | 3.661 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.8B | 182M | 6,484% |
Annual Yield % from dividends | 3.68 | 3.36 | 109% |
Returns for 1 year | 4.78 | 6.10 | 78% |
Returns for 3 years | 16.94 | 17.16 | 99% |
Returns for 5 years | 17.86 | 13.39 | 133% |
Returns for 10 years | N/A | 20.01 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 29.15 | -0.19 | -0.65% |
Fidelity Advisor Biotechnology I | |||
MSBWX | 11.77 | -0.16 | -1.34% |
Morgan Stanley American Resilience C | |||
CCQYX | 14.74 | -0.23 | -1.54% |
Columbia Disciplined Core Inst3 | |||
EXHAX | 25.70 | -0.41 | -1.57% |
Manning & Napier Pro-Blend Max Term S | |||
GINUX | 26.52 | -0.54 | -2.00% |
Goldman Sachs Small Cap Gr Insghts R6 |